Foghorn Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Foghorn Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Foghorn Therapeutics Inc
Rating: 1.28941675
Author: Trendlyne DVM scores

about

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, ...

4.89 -0.01 (-0.20%)

52.25% Fall from 52W High

7,767

XNAS Volume

XNAS 17 Sep, 2025 11:27 AM (EDT)

Not Eligible

Expensive Valuation

6.2 / 100

Technically Neutral

45.4 / 100

1Yr Price target upside is 139%

6 analysts

Foghorn Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Foghorn Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, ...

52.25% Fall from 52W High

SWOT Analysis

Foghorn Therapeutics Inc Live Price Chart